As Medistem Laboratories, Inc. (MDSM) creates shareholder value with new Intellectual Property and treatment protocols; forging ongoing profitable business relationships with large pharmaceutical firms may well prove to be the ultimate victory. Data from its licenses will enhance its ability to produce positive clinical trial data. Data that can truly benefit the large firms while making MDSM a valued development partner.
Let us hear your thoughts below: